Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 543,064 | 201,262 | 275,713 | 288,432 | 696,148 |
| Marketable Securities | 1,746,235 | 1,348,219 | 1,315,002 | 1,415,108 | 1,156,807 |
| Receivables | N/A | N/A | N/A | N/A | 1,254 |
| TOTAL | $2,327,632 | $1,579,139 | $1,624,730 | $1,729,202 | $1,879,281 |
| Non-Current Assets | |||||
| PPE Net | 24,289 | 24,814 | 25,284 | 23,697 | 22,865 |
| Investments And Advances | 12,128 | 0 | 0 | 0 | 0 |
| Intangibles | 71,278 | 71,545 | 71,813 | 72,080 | 72,347 |
| Other Non-Current Assets | 122,974 | 87,501 | 86,610 | 83,383 | 87,212 |
| TOTAL | $230,669 | $183,860 | $183,707 | $179,160 | $182,424 |
| Total Assets | $2,558,301 | $1,762,999 | $1,808,437 | $1,908,362 | $2,061,705 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 54,427 | 24,456 | 29,319 | 32,379 | 61,788 |
| Accrued Expenses | 96,615 | 78,011 | 67,681 | 53,175 | 74,694 |
| TOTAL | $163,914 | $110,863 | $105,332 | $93,723 | $143,851 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 126,830 | 82,717 | 81,142 | 86,057 | 88,545 |
| TOTAL | $129,183 | $85,832 | $84,257 | $89,172 | $91,660 |
| Total Liabilities | $293,097 | $196,695 | $189,589 | $182,895 | $235,511 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 185,913 | 168,219 | 167,039 | 164,986 | 164,690 |
| Common Shares | 18 | 16 | 16 | 16 | 16 |
| Retained earnings | -1,737,801 | -1,543,232 | -1,386,944 | -1,253,711 | -1,137,708 |
| Other shareholders' equity | 1,321 | 3,812 | -1,863 | -1,198 | 544 |
| TOTAL | $2,265,204 | $1,566,304 | $1,618,848 | $1,725,467 | $1,826,194 |
| Total Liabilities And Equity | $2,558,301 | $1,762,999 | $1,808,437 | $1,908,362 | $2,061,705 |